Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma. [PDF]
Xu L, Xu Y, Zhang F, Xu P, Wang L.
europepmc +1 more source
[Systemic therapeutic strategies for hepatocellular carcinoma: current status and prospects]. [PDF]
Yuan ZG, Ye SL.
europepmc +1 more source
[Application value of an aMAP score in predicting the occurrence of hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy]. [PDF]
Gao YF, Liu ZZ, Ma LY, Liu YX, Zhao CY.
europepmc +1 more source
[Analysis of <i>PIKFYVE</i> gene expression, clinical significance, and experimental validation based on TCGA database in hepatocellular carcinoma]. [PDF]
Wen LM +6 more
europepmc +1 more source
[Correlation analysis between expression of cytokeratin 19 and clinical pathological characteristics and prognosis of dual-phenotype hepatocellular carcinoma]. [PDF]
Yan YQ, Qu LJ, Ye XZ, Li M, Ouyang XJ.
europepmc +1 more source
[Hepatobiliary phase image manifestation classification and pathological features of nodules in nodules accompanied by hepatocellular carcinoma]. [PDF]
Xing F +5 more
europepmc +1 more source
[New progress in the first-line treatment of advanced hepatocellular carcinoma]. [PDF]
Zhang CH +4 more
europepmc +1 more source
[A case of hepatocellular carcinoma of fibrolamellar type misdiagnosed as a liver abscess]. [PDF]
Wang YW, Mo SY, Li YZ.
europepmc +1 more source
[Drug research and development and unmet needs for advanced-stage hepatocellular carcinoma]. [PDF]
Zhou HB, Hu HP.
europepmc +1 more source

